Authors: EVANS RS PESTOTNIK SL CLASSEN DC CLEMMER TP WEAVER LK ORME JF LLOYD JF BURKE JP

Citation: Rs. Evans et al., A COMPUTER-ASSISTED MANAGEMENT PROGRAM FOR ANTIBIOTICS AND OTHER ANTIINFECTIVE AGENTS, The New England journal of medicine, 338(4), 1998, pp. 232-238

Authors: CLASSEN DC PESTOTNIK SL EVANS RS LLOYD JF BURKE JP

Citation: Dc. Classen et al., ADVERSE DRUG EVENTS IN HOSPITALIZED-PATIENTS - EXCESS LENGTH OF STAY,EXTRA COSTS, AND ATTRIBUTABLE MORTALITY, JAMA, the journal of the American Medical Association, 277(4), 1997, pp. 301-306

Authors: BURKE JP CLASSEN DC PESTOTNIK SL EVANS RS LLOYD JF

Citation: Jp. Burke et al., ADVERSE DRUG EVENTS IN HOSPITALIZED-PATIENTS - REPLY, JAMA, the journal of the American Medical Association, 277(17), 1997, pp. 1353-1353

Authors: BURKE JP PESTOTNIK SL CLASSEN DC LLOYD JF

Citation: Jp. Burke et al., EVALUATION OF THE FINANCIAL IMPACT OF KETOROLAC TROMETHAMINE THERAPY IN HOSPITALIZED-PATIENTS, Clinical therapeutics, 18(1), 1996, pp. 197-211

Authors: BURKE JP PESTOTNIK SL CLASSEN DC LLOYD JF

Citation: Jp. Burke et al., A RETROSPECTIVE ANALYSIS OF TWICE-DAILY CEFOTAXIME COMPARED TO CONVENTIONAL THERAPY FOR THE TREATMENT OF INFECTIONS IN A USA HOSPITAL, Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 167-169